Clinical Trials in Philadelphia

Showing 6761-6780 of 15,860 trials

Assessing the Impact of a Financial Navigation Program for Patients With Multiple Myeloma

NCT05448196

The study is a randomized controlled trial to develop and evaluate a coordinated financial navigation program at the Abramson Cancer Center (ACC) for patients with multiple myeloma and identify barriers to its broader implementation.

Multiple Myeloma

Abramson Cancer Center at Penn Medicine103 participantsStarted Mar 2022

Philadelphia, Pennsylvania, United States

COMPLETEDPhase 2< 1 mile

Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach

NCT00003237

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug, and giving them after surgery, may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy, consisting of paclitaxel and cisplatin, given after surgery in treating patients with cancer of the esophagus or stomach.

Esophageal CancerGastric Cancer

Eastern Cooperative Oncology Group55 participantsStarted Jun 1998

Chicago, Illinois, United States • Chicago, Illinois, United States • Evanston, Illinois, United States +27 more locations

Assessing the Impact of a Financial Navigation Program for Patients With Multiple Myeloma

Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach

Find Trials by Condition in Philadelphia

Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer

Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia

Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia

Eribulin Mesylate in Combination With Intermittent Erlotinib in Patients With Previously Treated, Advanced Non-Small Cell Lung Cancer

Chronic HBV Management for Asian American

Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Dacarbazine in Subjects With Soft Tissue Sarcoma

Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic Leukemia

Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer

ClearSight Validation in Pediatrics

Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease

Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer

Study to Assess the Efficacy and Safety of Umbralisib in Participants With Non-Follicular Indolent Non-Hodgkin's Lymphoma

Mobile Devices to Detect Early Pneumonitis in Stage III NSCLC Patients on Durvalumab.

Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma

A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Treatment of Physician's Choice in Subjects With Advanced Non-Small Cell Lung Cancer

Clinical Performance of Senofilcon A Investigational Lens

Study of Dasatinib vs Imatinib in Patients With Chronic Myeloid Leukemia (CML) Who Did Not Have Favorable Response to Imatinib

High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis